Mitochondrial-derived peptide / MOTS-c (human)
16-amino acid peptide encoded in mitochondrial 12S rRNA. Discovered by Pinchas Cohen (USC) in 2015. Regulates metabolic homeostasis via AMPK pathway. Improves insulin sensitivity, promotes fat oxidation. Exercise mimetic — skeletal muscle expression increases with physical activity.
Encoded in mitochondrial DNA (MT-RNR1). Under metabolic stress, translocates to nucleus → interacts with AMPK pathway. Activates AICAR-sensitive pathways. Increases glucose uptake in skeletal muscle. Promotes fat oxidation. Inhibits folate cycle / de novo purine synthesis. Enhances mitochondrial biogenesis retrograde signaling.
5-15mg SC daily (most common) for 2-4 weeks cycles. Some protocols use 10mg IM daily. Pre-load with AICAR for synergy (experimental).
MOTS-c: a mitochondrial-derived peptide regulating metabolism
MOTS-c prevents obesity and insulin resistance in mice
CYP19A1 and MOTS-c: interaction with AICAR
MOTS-c improves metabolic health: comprehensive review
Lyophilized: -20°C for long-term, 2-8°C for short-term. Reconstituted: use immediately or within 24 hours refrigerated.